A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis

Clinical trial NCT05118919 · COMPLETED

Trial details

NCT number: NCT05118919
Sponsor: BioGaia Pharma AB
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2022-02-09
Primary completion: 2024-12-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.